Works matching IS 11707690 AND DT 2023 AND VI 41 AND IP 8

Results: 9

Time to Close the Gap Between Guidelines and the Reimbursement Policy for Diabetes Treatment in Turkey.
Published in:
PharmacoEconomics, 2023, v. 41, n. 8, p. 843, doi. 10.1007/s40273-023-01282-7
By:
- Güven, Alper Tuna
Publication type:
Article
Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers.
Published in:
PharmacoEconomics, 2023, v. 41, n. 8, p. 1011, doi. 10.1007/s40273-023-01281-8
By:
- Meunier, Aurelie;
- Longworth, Louise;
- Gomes, Manuel;
- Ramagopalan, Sreeram;
- Garrison, Louis P.;
- Popat, Sanjay
Publication type:
Article
A Systematic Review of the Cost-Effectiveness Analyses of Anaplastic Lymphoma Kinase (ALK) Inhibitors in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC).
Published in:
PharmacoEconomics, 2023, v. 41, n. 8, p. 945, doi. 10.1007/s40273-023-01279-2
By:
- Chayab, Lara;
- Konstantelos, Natalia;
- Leighl, Natasha B.;
- Tadrous, Mina;
- Wong, William W. L.
Publication type:
Article
Economic Burden of Idiopathic Pulmonary Fibrosis in Spain: A Prospective Real-World Data Study (OASIS Study).
Published in:
PharmacoEconomics, 2023, v. 41, n. 8, p. 999, doi. 10.1007/s40273-023-01278-3
By:
- Rodríguez-Nieto, Maria Jesus;
- Cano-Jiménez, Esteban;
- Romero Ortiz, Ana D.;
- Villar, Ana;
- Morros, Marta;
- Ramon, Alba;
- Armengol, Silvia
Publication type:
Article
Cost-Effectiveness Analysis of MammaPrint<sup>®</sup> to Guide the Use of Endocrine Therapy in Patients with Early-Stage Breast Cancer.
Published in:
PharmacoEconomics, 2023, v. 41, n. 8, p. 981, doi. 10.1007/s40273-023-01277-4
By:
- Luyendijk, Marianne;
- Jager, Agnes;
- Buijs, Sanne M.;
- Siesling, Sabine;
- Groot, Carin A. Uyl-de;
- Blommestein, Hedwig M.
Publication type:
Article
Cost Effectiveness of Strategies to Manage Atrial Fibrillation in Middle- and High-Income Countries: A Systematic Review.
Published in:
PharmacoEconomics, 2023, v. 41, n. 8, p. 913, doi. 10.1007/s40273-023-01276-5
By:
- Okafor, Charles;
- Byrnes, Joshua;
- Stewart, Simon;
- Scuffham, Paul;
- Afoakwah, Clifford
Publication type:
Article
Oral Azacitidine for Maintenance Treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Published in:
PharmacoEconomics, 2023, v. 41, n. 8, p. 857, doi. 10.1007/s40273-023-01272-9
By:
- Witlox, Willem;
- Grimm, Sabine;
- Howick, Jeremy;
- Armstrong, Nigel;
- Ahmadu, Charlotte;
- McDermott, Kevin;
- Otten, Thomas;
- Noake, Caro;
- Wolff, Robert;
- Joore, Manuela
Publication type:
Article
Cost-Effectiveness of Thrombopoietin Mimetics in Patients with Thrombocytopenia: A Systematic Review.
Published in:
PharmacoEconomics, 2023, v. 41, n. 8, p. 869, doi. 10.1007/s40273-023-01271-w
By:
- Van Remoortel, Hans;
- Scheers, Hans;
- Avau, Bert;
- Georgsen, Jørgen;
- Nahirniak, Susan;
- Shehata, Nadine;
- Stanworth, Simon J.;
- De Buck, Emmy;
- Compernolle, Veerle;
- Vandekerckhove, Philippe
Publication type:
Article
How Much Better is Faster? Value Adjustments for Health-Improvement Sequences.
Published in:
PharmacoEconomics, 2023, v. 41, n. 8, p. 845, doi. 10.1007/s40273-023-01266-7
By:
- Johnson, F. Reed;
- Gonzalez, Juan Marcos;
- Sheehan, John J.;
- Reed, Shelby D.
Publication type:
Article